Business Wire

Sonar’s New, Powerful Deep-Analysis Capability Finds Hidden Code Level Security Issues

2.8.2023 16:00:00 EEST | Business Wire | Press release

Share

Sonar, the leading Clean Code solution provider, today announced a significant advancement of its Clean Code offering – developers can now automatically discover and fix code security issues arising from interactions between user source code and third-party, open-source libraries.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230802497889/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Sonar deeper SAST finds hidden code level security issues (Graphic: Business Wire)

Referred to as deeper SAST, the new advanced detection addresses issues that traditional SAST tools miss by not following the flow within library code. Traditional SAST vendors analyze user application code. These tools do not scan the combined code, and flag libraries in an unsophisticated way, ignoring the context and use within the library. The result is that library features are considered black boxes, leaving organizations in the dark about whether they're truly secure for a given context or not. Moreover, these tools typically support only a handful of popular frameworks, often requiring up-front configurations for setup. All of this leads to the security issues created by the unique usage of third-party open source libraries going undetected.

“Code is code, whether it is written by a developer in your team or whether it comes as part of a library that is solving a specific problem. The two different approaches always bothered me, and I am thrilled that we are now able to analyze all codes the same way at once, solving what was considered an impossible problem,” said Olivier Gaudin, CEO and co-founder of Sonar. “With the deeper SAST advancements made to our Clean Code solution, organizations can discover these vulnerabilities and resolve them quickly as code is developed.”

Sonar addresses the gap of traditional SAST through its fine-grained analysis of user source code interactions with external dependencies, all without the need for any special configuration or incremental costs. This deeper SAST innovation furthers Sonar’s mission to equip organizations to achieve a state of Clean Code — code that is consistent, intentional, adaptable, and responsible. When code adheres to these characteristics, software becomes reliable, maintainable, and secure.

“It’s estimated that over 90% of applications leverage third-party libraries and interact with the code within them, but most SAST tools don’t tell developers which dependencies make their code vulnerable. Security is mission-critical, and the more issues you find and fix before they have the ability to cause you harm, the better off your business will be,” said Rik Turner, a Senior Principal Analyst covering cybersecurity at Omdia. “This is the essence of the proactive security wave we are seeing across the cyber sector: find it and fix it before it’s exploited.”

Sonar deeper SAST functionality is available at no additional cost within commercial editions of SonarQube (self-managed) and SonarCloud (cloud-based) — industry-leading static analysis code review tools that continuously inspect and analyze the codebase using quality gates to determine if code meets the defined standards for development and production. Deeper SAST currently supports Java, C#, and TypeScript programming languages and covers thousands of the topmost and commonly used open-source libraries, including their subsequent (transitive) dependencies.

Achieving a Clean Code State

Sonar empowers development teams to write Clean Code by providing them with the right tools and best practices, so they can spend less time fixing issues and more time meeting delivery and business goals. Pairing the Sonar solution with the company’s Clean as You Code methodology — set standards for keeping new, added, or edited code clean — and its educational guidance for code called ‘Learn as You Code,’ developers have faster issue remediation and delivery, code enhancement, and can further professional growth and team retention. Today, there are over seven million developers using Sonar.

Sonar also actively engages with its ecosystem and customer communities, in addition to partnerships with several universities for security research projects, and the open source software and start-up communities. Additionally, Sonar has a dedicated team of security researchers that find and responsibly disclose exploitable zero-day vulnerabilities in open-source software; these findings are used as inspiration for new security rules and detections to help find vulnerabilities.

Learn more about our deeper SAST innovation and Sonar solution (SonarQube, SonarCloud, SonarLint). Meet Sonar experts at Black Hat USA, booth #2760, August 8-10.

About Sonar

Sonar empowers developers and organizations to systematically achieve a state of Clean Code so that all code is fit for development and production. By applying the Sonar Clean as You Code methodology, organizations minimize risk, reduce technical debt, and derive more value from their software in a predictable and sustainable way.

The open source and commercial Sonar solution – SonarLint, SonarCloud, and SonarQube – supports over 30 programming languages, frameworks, and infrastructure technologies. Trusted by more than 400,000 organizations globally to clean more than half a trillion lines of code, Sonar is integral to delivering better software.

To learn more about Sonar, please visit https://www.sonarsource.com/company/about/.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Katie Hyman
Senior PR Manager, Sonar
katie.hyman@sonarsource.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 14:42:00 EEST | Press release

2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (Photo: AETOSWire) Net profit from the Group’s businesses increased by 2,301% year-on-year (YoY), driven by the consolidation of Tendam and the mega-merger to form 2PointZero Group, and growth was also supported by new investments in African financial services, entry into the European packaging markets, and steady operational progress across all verticals, bringing the total reported net profit to AED 7.7 billion. Through continued operational integr

Datroway ® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 09:30:00 EEST | Press release

Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from the TROPION-Breast02phase 3 trial, which were presented at the 2025 European Society for Medical Oncology Congress and subsequently published in Annals of Oncology. In TROPION-Breast02, which included patients with metastatic TNBC who experienced early relapse following prior treatment, Datroway demonstrated a statis

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 09:30:00 EEST | Press release

Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said

Half-Year Report on SES’s Liquidity Contract31.7.2026 08:30:00 EEST | Press release

Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th

SES: Disclosure of Share Buyback Transactions31.7.2026 08:30:00 EEST | Press release

In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye